Physician

Peter J Malouf, D.O.

According to 2025 Medicare claims, Peter Malouf, D.O. (NPI: 1225047012) practices dermatology in the Fort Worth-Arlington-Grapevine, TX market, with the plurality of this provider's patient population coming from Johnson, TX. This provider's primary affiliated billing organization is CONCIERGE DERMATOLOGY MANAGEMENT, LLC (NPI: 1134615206; TIN: 830862048) and primary practice location at 76132-3900.

Malouf's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 514 traditional Medicare patients, billed 3,097 HCPCS/CPT codes, and received $194,759 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 1,205 prescription claims across 477 beneficiaries totaling $86,150 in drug costs, led by Clobetasol Propionate (Clobetasol Propionate). Open Payments data shows 3 records totaling $56. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $132,455 to $86,150. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	848	3,605	$227,710
2016	400	1,545	$180,920
2017	216	684	$99,331
2018	28	87	$6,022
2019	187	979	$72,074
2020	254	1,180	$102,885
2021	322	1,708	$121,865
2022	493	2,892	$160,948
2023	437	2,513	$170,804
2024	514	3,097	$194,759

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	599	1,243	$132,455
2016	474	968	$98,366
2017	191	290	$18,361
2018	46	104	$11,481
2019	168	359	$17,569
2020	231	544	$27,670
2021	305	642	$28,642
2022	342	743	$133,612
2023	422	887	$41,370
2024	477	1,205	$86,150

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17110	Destruction of skin growth, 1-14 growths	144	206	$76
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	225	225	$65
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	377	700	$58
17000	Destruction of precancer skin growth, 1 growth	203	304	$36
17003	Destruction of precancer skin growth, 2-14 growths	164	987	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Clobetasol Propionate	Clobetasol Propionate	170	3,864	$4,947
Doxycycline Hyclate	Doxycycline Hyclate	268	3,583	$3,167
Triamcinolone Acetonide	Triamcinolone Acetonide	136	3,810	$1,896
Fluorouracil	Fluorouracil	21	616	$1,583
Ketoconazole	Ketoconazole	106	4,017	$1,347

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$56	E.R. Squibb & Sons, L.L.C.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Peter J. Malouf, D.O.?

Tedicare shows public-source Medicare data for Peter J. Malouf, D.O. (NPI 1225047012), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Peter J. Malouf, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Peter J. Malouf, D.O.?

Peter J. Malouf, D.O. is linked to CONCIERGE DERMATOLOGY MANAGEMENT, LLC (billing NPI 1134615206) in the available physician profile data.

Does Peter J. Malouf, D.O. have Open Payments data?

Peter J. Malouf, D.O. has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.